The implementation rate of the decision aid in daily care is expected to depend on barriers perceived by care providers and/or patients. Use of the decision aid is expecetd to decrease decisional conflict and increase knowledge in patients.
ID
Bron
Verkorte titel
Aandoening
Decision aid for Localised Prostate cancer
Prostaatkanker keuzehulp
Ondersteuning
Nijmegen, the Netherlands
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Implementation rate of the decision aid in routine care<br>
Barriers and facilitators for decision aid use
Achtergrond van het onderzoek
To address the limited use of decision support in oncology daily practice, the implementation of a decision aids (DA) is studied in patients with localized prostate cancer who had more than one treatment option (surgery, external radiotherapy, brachytherapy and/or active surveillance). This study focusses primarily on the barriers and facilitators for DA use.
Both care providers and patients fill out questionnaires on decision making and on the use of the DA. The implementation rate was calculated as the portion of eligible patients that received a DA, using national cancer registry data on the number of eligible patients per hospital.
In addition, the effect of the DA is studied by comparing the intervention group (receiving usual care plus DA) with a control group (receiving usual care without DA).
Doel van het onderzoek
The implementation rate of the decision aid in daily care is expected to depend on barriers perceived by care providers and/or patients.
Use of the decision aid is expecetd to decrease decisional conflict and increase knowledge in patients.
Onderzoeksopzet
Patient questionnaires were filled out after the treatment choice was made but before the treatment was carried out.
Care provider questionnaires were filled out after about nine months of using the decision aid
Onderzoeksproduct en/of interventie
Care providers present a decision aid to their patients with prostate cancer to involve them in the choice of their treatment.
Care providers and patients fill out questionnaires.
A control group of patients receive usual care without decision aid. They also fill out questionnaires.
Publiek
Julia van Tol-Geerdink
Nijmegen 6500 HB
The Netherlands
024-3614515
julia.vantol-geerdink@radboudumc.nl
Wetenschappelijk
Julia van Tol-Geerdink
Nijmegen 6500 HB
The Netherlands
024-3614515
julia.vantol-geerdink@radboudumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Men with localized prostate cancer
Eligible for two or more treatment options
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Insufficient knowledge of the Dutch language
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL6098 |
NTR-old | NTR6245 |
Ander register | Radboudumc : CZ-201300071 |
Samenvatting resultaten
* van Tol-Geerdink JJ, Cuypers M, Al-Itejawi HHM, van Uden-Kraan CF, de Vries M, Stalmeier PFM. Implementation and effect of three Dutch decision aids for prostate cancer; Results from the JIPPA study. Eur Urol S15 (13), E1580-1581, 2016
* Cuypers M, Lamers R, Kil P, van Tol-Geerdink J, van Uden-Kraan C, van de Poll-Franse L, de Vries M. Uptake and usage of an online prostate cancer treatment decision aid in Dutch clinical practice: A quantitative analysis from the PCPCC trial. Health Informatics Journal 25(4), 1498–1510, 2019
* van Tol-Geerdink JJ, Somford DM, van Oort IM, Wijburg CJ, Geboers AD, van Uden C, de Vries M, Stalmeier PFM. Implementation of a decision aid for localized prostate cancer in routine care; A successful implementation strategy. Health Informatics Journal doi: 10.1177/1460458219873528 (epub 2019)